2016

Progressive vascular remodelling, endothelial dysfunction and stiffness in mesenteric resistance arteries in a rodent model of chronic kidney disease

oaladhami, 719, Journal Article, , Progressive vascular remodelling, endothelial dysfunction and stiffness in mesenteric resistance arteries in a rodent model of chronic kidney disease. (2016). Vascular Pharmacology 81, 42-52, 2016, 81(7), 42-52.

2015

Variations in GC–MS response between analytes and deuterated analogs

mkhanfar, 645, Journal Article, , Variations in GC–MS response between analytes and deuterated analogs. (2015). Chromatographia 78 (3), 251-258, 2015, 78, 251–258.

2015

Abnormalities associated with progressive aortic vascular dysfunction in chronic kidney disease

oaladhami, 719, Journal Article, , Abnormalities associated with progressive aortic vascular dysfunction in chronic kidney disease. (2015). Frontiers in Physiology 6, 150, 2015, 6(150).

2015

Validated HPLC method for simultaneous estimation of khellol glucoside, khellin and visnagin in Ammi visnaga L. fruits and pharmaceutical preparations.

kelnahriry, 1138, Journal Article, , Validated HPLC method for simultaneous estimation of khellol glucoside, khellin and visnagin in Ammi visnaga L. fruits and pharmaceutical preparations. (2015). Nat Prod Res., 29(7).

2015

Variations in GC–MS Response Between Analytes and Deuterated Analogs

mkhanfar, 645, Journal Article, , Variations in GC–MS Response Between Analytes and Deuterated Analogs. (2015). Chromatographia, 78, 251–258.

2015

Protective cardiorenal effects of spironolactone in a rodent model of polycystic kidney disease

oaladhami, 719, Journal Article, , Protective cardiorenal effects of spironolactone in a rodent model of polycystic kidney disease. (2015). Clinical and Experimental Pharmacology and Physiology 42 (4), 353-360, 2015, 4, 353-360.

2015

Olive oil‐derived oleocanthal as potent inhibitor of mammalian target of rapamycin: biological evaluation and molecular modeling studies

mkhanfar, 645, Journal Article, , Olive oil‐derived oleocanthal as potent inhibitor of mammalian target of rapamycin: biological evaluation and molecular modeling studies. (2015). Phytotherapy Research 29 (11), 1776-1782, 2015.

2015

High blood pressure as a driver of structural and biomechanical changes in mesenteric resistance arteries in chronic kidney disease

oaladhami, 719, Journal Article, , High blood pressure as a driver of structural and biomechanical changes in mesenteric resistance arteries in chronic kidney disease. (2015). United States: Lippincott Williams & Wilkins, 2015.

2015

Design and evaluation of 3-(benzylthio) benzamide derivatives as potent and selective SIRT2 inhibitors

mkhanfar, 645, Journal Article, , Design and evaluation of 3-(benzylthio) benzamide derivatives as potent and selective SIRT2 inhibitors. (2015). ACS Medicinal Chemistry Letters 6 (5), 607-611, 2015, 6, 607–611.

2015

Design and evaluation of 3-(benzylthio) benzamide derivatives as potent and selective SIRT2 inhibitors

mkhanfar, 645, Journal Article, , Design and evaluation of 3-(benzylthio) benzamide derivatives as potent and selective SIRT2 inhibitors. (2015). ACS Medicinal Chemistry Letters, 6, 607–611.